Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Corneal Neovascularization D016510 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
HIV Infections D015658 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Reperfusion Injury D015427 65 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Wounds and Injuries D014947 20 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Vitamin D Deficiency D014808 13 associated lipids
Viremia D014766 4 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Uremia D014511 33 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Toxemia D014115 3 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thrombosis D013927 49 associated lipids
Thrombocytosis D013922 4 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombasthenia D013915 4 associated lipids
Thalassemia D013789 8 associated lipids
Tangier Disease D013631 8 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Stomatitis D013280 14 associated lipids
Stomach Ulcer D013276 75 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Spasm D013035 5 associated lipids
Sneezing D012912 6 associated lipids
Shock, Traumatic D012774 4 associated lipids
Shock, Septic D012772 11 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Hines KL and Fisher RA Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis. 1992 Am. J. Physiol. pmid:1375439
Livio M et al. Role of platelet-activating factor in primary hemostasis. 1988 Am. J. Physiol. pmid:2837916
Whittle BJ et al. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. 1986 Am. J. Physiol. pmid:3789144
Zimmerman BJ et al. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. 1994 Am. J. Physiol. pmid:8160832
Huber W et al. Leukotriene B4 and C4 production in isolated rat gastric mucosal cells. 1993 Am. J. Physiol. pmid:8279553
Del Maschio A et al. Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. 1990 Am. J. Physiol. pmid:2156456
DeFily DV et al. PAF attenuates endothelium-dependent coronary arteriolar vasodilation. 1996 Am. J. Physiol. pmid:8764261
Xie J et al. Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension. 1997 Am. J. Physiol. pmid:9249487
Yamazaki M et al. Modulation of leukotriene B4 and platelet-activating factor binding to neutrophils. 1991 Am. J. Physiol. pmid:1653524
Buerke M et al. Isolated cardiac myocytes are sensitized by hypoxia-reoxygenation to neutrophil-released mediators. 1994 Am. J. Physiol. pmid:8304493
Kurose I et al. Microvascular dysfunction induced by nonsteroidal anti-inflammatory drugs: role of leukocytes. 1996 Am. J. Physiol. pmid:8779980
Gozal D et al. Platelet-activating factor modulates cardiorespiratory responses in the conscious rat. 1998 Am. J. Physiol. pmid:9688699
Halonen M et al. Anatomic basis for species differences in peripheral lung strip contraction to PAF. 1990 Am. J. Physiol. pmid:2382734
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Neuwirth R et al. Extra- and intracellular metabolism of platelet-activating factor by cultured mesangial cells. 1989 Am. J. Physiol. pmid:2705543
Owen CA et al. Cytokines regulate membrane-bound leukocyte elastase on neutrophils: a novel mechanism for effector activity. 1997 Am. J. Physiol. pmid:9124593
Wood JG et al. Gastric microvascular actions of platelet-activating factor: role of leukocytes. 1992 Am. J. Physiol. pmid:1550241
Conyers G et al. A factor in serum lowers resistance and opens tight junctions of MDCK cells. 1990 Am. J. Physiol. pmid:2221039
Kvietys PR et al. Ethanol enhances leukocyte-endothelial cell interactions in mesenteric venules. 1990 Am. J. Physiol. pmid:2221068
Harris NR et al. Capillary filtration during acute inflammation: role of adherent neutrophils. 1993 Am. J. Physiol. pmid:7902014
Gallin EK Evidence for a Ca-activated inwardly rectifying K channel in human macrophages. 1989 Am. J. Physiol. pmid:2750892
Esplugues JV and Whittle BJ Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats. 1989 Am. J. Physiol. pmid:2919672
Ardaillou N et al. Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. 1985 Am. J. Physiol. pmid:3918460
Zhou W et al. Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. 1992 Am. J. Physiol. pmid:1443133
Galens S et al. Assessment of agonist- and cell-mediated responses in airway microsections by computerized videomicrometry. 1995 Am. J. Physiol. pmid:7900832
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Sun X et al. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. 1997 Am. J. Physiol. pmid:9252509
Saito M et al. Association of granular exocytosis with Ca(2+)-activated K+ channels in human eosinophils. 1997 Am. J. Physiol. pmid:9252535
Gulbins E et al. Effects of rC5a on the circulation of normal and split hydronephrotic rat kidneys. 1993 Am. J. Physiol. pmid:8342619
Hanglow AC et al. Effects of platelet-activating factor on ion transport in isolated rat jejunum. 1989 Am. J. Physiol. pmid:2597284
Sánchez-Crespo M et al. Presence in normal human urine of a hypotensive and platelet-activating phospholipid. 1983 Am. J. Physiol. pmid:6859262
Rabe KF et al. Contraction of human bronchial smooth muscle caused by activated human eosinophils. 1994 Am. J. Physiol. pmid:7943259
Mózes T et al. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. 1989 Am. J. Physiol. pmid:2802004
Kobayashi I et al. Platelet-activating factor modulates microvascular transport by stimulation of protein kinase C. 1994 Am. J. Physiol. pmid:8160825
Hines KL et al. PAF increases hepatic vascular resistance and glycogenolysis in vivo. 1991 Am. J. Physiol. pmid:1848410
Schlondorff D et al. Relationship of GTP-binding proteins, phospholipase C, and PGE2 synthesis in rat glomerular mesangial cells. 1989 Am. J. Physiol. pmid:2492160
Bellan JA et al. Analysis of pulmonary and systemic vascular responses to platelet-activating factor in the cat. 1992 Am. J. Physiol. pmid:1379004
Snyder F Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. 1990 Am. J. Physiol. pmid:2240190
Arnould T et al. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. 1993 Am. J. Physiol. pmid:8098907
Kubes P et al. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. 1990 Am. J. Physiol. pmid:2240225
Shibamoto T et al. PAF increases capillary pressure but not vascular permeability in isolated blood-perfused canine lungs. 1993 Am. J. Physiol. pmid:8498559
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Koyama S et al. Bradykinin stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. 1995 Am. J. Physiol. pmid:7631812
Miura S et al. Attenuation of endotoxin-induced intestinal microcirculatory damage by eicosapentanoic acid. 1993 Am. J. Physiol. pmid:8498509
Martins MA et al. Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. 1991 Am. J. Physiol. pmid:1722649
Huang Q et al. Neutrophil-dependent augmentation of PAF-induced vasoconstriction and albumin flux in coronary arterioles. 1998 Am. J. Physiol. pmid:9746460
Johnson A et al. Tumor necrosis factor-alpha primes pulmonary hemodynamic response to N-formyl-L-methionyl-L-leucyl-L-phenylalanine. 1991 Am. J. Physiol. pmid:1656789
Milhoan KA et al. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. 1992 Am. J. Physiol. pmid:1415623
Dorn GW and Davis MG Differential megakaryocytic desensitization to platelet agonists. 1992 Am. J. Physiol. pmid:1415671
Faden AI and Tzendzalian PA Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. 1992 Am. J. Physiol. pmid:1415805